International Marijuana Business News – Asia & Oceania
A panel set up by Japan’s Ministry of Health, Labor and Welfare is recommending that the nation’s lawmakers carve out a legal pathway to import scientifically proven medical cannabinoids, similar to the approach South Korea took about four years ago.
The largest private company in Thailand has its eyes on CBD foods as the nation decriminalizes marijuana and hemp.
Cann Group Limited, an Australian cannabis producer, said it has entered into an exclusive evaluation and option deal with GSK Consumer Healthcare, a subsidiary of U.K. drugmaker GlaxoSmithKline.
Australian cannabis producer Little Green Pharma says it plans to “demerge” the ownership of its psychedelics unit, Reset Mind Sciences, so the respective companies can pursue their strategies as independent businesses.
Creso Pharma said it is buying Colorado-based CBD maker Sierra Sage Herbs in an all-stock deal worth $21 million, positioning the Australian cannabis producer to enter the U.S. market.
Australia’s Department of Health, preparing to overhaul its medical cannabis regulations, is poised to require that all products imported into the country’s small but growing market be produced in accordance with Good Manufacturing Practice (GMP).
Marijuana track-and-trace service Metrc signed a contract to provide seed-to-sale traceability services to the U.S. territory of Guam, the Florida-based company said Monday.
